Combined Therapy of Zanubrutinib and Zilovertamab in the Inhibition of Invasive Capability of Chronic Lymphocytic Leukemia Cells

被引：0
|
作者：
Hasan, Md Kamrul [1 ]
Widhopf, George F., II [2 ]
Kipps, Thomas J. [1 ]
机构：
[1] Univ Calif San Diego, Moores Canc Ctr, Ctr Novel Therapeut, La Jolla, CA USA
[2] Ctr Novel Therapeut, Sch Med, La Jolla, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-191114
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Zanubrutinib in Chronic Lymphocytic Leukemia
    Liang, Yang
    Gale, Robert P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (18): : 1719 - 1720
  • [2] Zanubrutinib in Chronic Lymphocytic Leukemia Reply
    Brown, Jennifer R.
    Cohen, Aileen
    Shadman, Mazyar
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (18): : 1720 - 1721
  • [3] Zanubrutinib for the treatment of chronic lymphocytic leukemia
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Labanca, Caterina
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (14) : 1537 - 1543
  • [4] The Use of Zanubrutinib in Chronic Lymphocytic Leukemia
    Brander, Danielle M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (12) : 1 - 4
  • [5] Zanubrutinib for the treatment of chronic lymphocytic leukemia
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Labanca, Caterina
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (13) : 1409 - 1413
  • [6] The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Zou, Yi-Xin
    Zhu, Hua-Yuan
    Li, Xiao-Tong
    Xia, Yi
    Miao, Kou-Rong
    Zhao, Si-Shu
    Wu, Yu-Jie
    Wang, Li
    Xu, Wei
    Li, Jian-Yong
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 392 - 400
  • [7] The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Zou, Yi-Xin
    Zhu, Hua-Yuan
    Li, Xiao-Tong
    Xia, Yi
    Miao, Kou-Rong
    Zhao, Si-Shu
    Wu, Yujie
    Wang, Li
    Xu, Wei
    Li, Jianyong
    LEUKEMIA & LYMPHOMA, 2020, 61 : 5 - 6
  • [8] Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Brown, J. R.
    Eichhorst, B.
    Hillmen, P.
    Jurczak, W.
    Kazmierczak, M.
    Lamanna, N.
    O'Brien, S. M.
    Tam, C. S.
    Qiu, L.
    Zhou, K.
    Simkovic, M.
    Mayer, J.
    Gillespie-Twardy, A.
    Ferrajoli, A.
    Ganly, P. S.
    Weinkove, R.
    Grosicki, S.
    Mital, A.
    Robak, T.
    Osterborg, A.
    Yimer, H. A.
    Salmi, T.
    Wang, M. -D. -Y.
    Fu, L.
    Li, J.
    Wu, K.
    Cohen, A.
    Shadman, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (04): : 319 - 332
  • [9] Invasive Aspergillosis in Chronic Lymphocytic Leukemia: Therapy and Outcomes
    Duma, Narjust
    Paludo, Jonas
    Kabat, Brian
    Tande, Aaron
    Chaffee, Kari G.
    Call, Timothy G.
    Kenderian, Saad Sirop
    Ding, Wei
    Leis, Jose F.
    Larson, Melissa C.
    Chanan-Khan, Asher A.
    Conte, Michael
    Schwager, Susan Marie
    Slager, Susan L.
    Kay, Neil E.
    Shanafelt, Tait D.
    Parikh, Sameer A.
    BLOOD, 2017, 130
  • [10] Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma
    Javidi-Sharifi, Nathalie
    Brown, Jennifer R.
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (06) : 201 - 210
12345